Log in to save to my catalogue

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA gen...

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA gen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_860204ae204a497986d88eec577b5261

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling

About this item

Full title

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling

Publisher

United States: John Wiley & Sons, Inc

Journal title

Molecular genetics & genomic medicine, 2020-02, Vol.8 (2), p.e1079-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
One of the major challenges in managing invasive breast cancer (BC) is the lack of reliable biomarkers to track response. Circulating tumor DNA (ctDNA) from liquid biopsy, as a candidate biomarker, provides a valuable assessment of BC patients. In this retrospective study, we evaluated the utility of ctDNA to reflect the efficacy of t...

Alternative Titles

Full title

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_860204ae204a497986d88eec577b5261

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_860204ae204a497986d88eec577b5261

Other Identifiers

ISSN

2324-9269

E-ISSN

2324-9269

DOI

10.1002/mgg3.1079

How to access this item